Stocklytics Platform
CLNN
Clene
CLNNW4
$0.06arrow_drop_up20.48%$0.01
Penny Stock
CLNN
CLNNW4

$0.06

arrow_drop_up20.48%

Performance History

Chart placeholder
Key Stats
Open$0.04
Prev. Close$0.04
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio-
LOWHIGH
Day Range0.04
0.06
52 Week Range0.02
0.09
Ratios
Revenue-
EBITDA Margin %-
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Clene (CLNNW)

Clene Inc. (CLNNW) is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutic products for the treatment of neurodegenerative diseases. The company leverages its proprietary nanotechnology-based platform to create innovative drug candidates that target the underlying causes of neurological disorders. With a strong focus on precision medicine, Clene aims to transform the treatment landscape for patients suffering from conditions such as neurodegenerative diseases.
As of the latest stock price update, Clene Inc. (CLNNW) is trading at $10.25 per share. Over the past year, the stock has been trading in a 52-week range of $7.50 to $13.65. The current day range for CLNNW is $9.80 to $10.50. The trading volume for Clene Inc. is steady, indicating a healthy interest from investors.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add Clene to watchlist

Keep an eye on Clene

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

Is Clene (CLNNW) a growth stock?

Clene (CLNNW) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Clene as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is the 52-week high and low for Clene (CLNNW)?

For Clene (CLNNW), the 52-week high is $0.1, which is 63.83% from the current price. The 52-week low is $0.02, the current price is 159.74% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

What is Clene's (CLNNW) price per share?

The current price per share for Clene (CLNNW) is $0.06. The stock has seen a price change of $0.01 recently, indicating a 20.48% change. This reflects the stock's recent market performance and investor sentiment.
help

What is Clene (CLNNW) stock price performance year to date (YTD)?

As of the latest data, Clene (CLNNW) has a year-to-date price change of 31%. Over the past month, the stock has experienced a price change of 62.16%. Over the last three months, the change has been 71.43%. Over the past six months, the figure is 0.17%.
help

Is Clene (CLNNW) a profitable company?

Clene (CLNNW) has a net income of -$49.5M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -8.12K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 38.27%, providing insight into the company's sales performance and growth. Operating income is noted at -$40.54M. Furthermore, the EBITDA is -$34.4M.
help

What is the market capitalization of Clene (CLNNW)?

Clene (CLNNW) has a market capitalization of . The average daily trading volume is 5.18K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media